People with Parkinson’s disease are to benefit from cutting edge AI technology that allows neuroscientists to safely test medication and treatment on a ‘digital twin’ brain, thanks to a £1m funding ...
Cala Health, the non-invasive bioelectronic medicine leader, today announced it has completed the initial closing of an oversubscribed $50 million growth round, co-led by Vertex Growth Fund and Nexus ...